The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 2×
“Second, although p16INK4a is lost in most melanoma cell lines (Kamb et al., 1994), it is less commonly lost in clinical samples of melanoma.”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799
Self-citationIndra, A. K., Warot, X., Brocard, J., Bornert, J.-M., Xiao, J.-H., Chambon, P., & Metzger, D. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.22.4324 · Cited by 756
Patton, E. E., Widlund, H. R., Kutok, J. L., Kopani, K. R., Amatruda, J. F., Murphey, R. D., Berghmans, S., Mayhall, E. A., Traver, D., Fletcher, C. D. M., et al. (2005) · Current Biology · doi:10.1016/j.cub.2005.01.031 · Cited by 664
Immunohistochemical characteristics of melanoma
Ohsie, S. J., Sarantopoulos, G. P., Cochran, A. J., & Binder, S. W. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00891.x · Cited by 593
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 2×
“, 2005), so we examined whether Braf could also stimulate metastatic melanomas in p16 null animals by crossing the Braf/CreERT2 mice onto a p16 null background (note that these mice still express p19 [Krimpenfort et al., 2001]).”
BackgroundSuppression of BRAF(V599E) in human melanoma abrogates transformation.
Hingorani, S. R., Jacobetz, M. A., Robertson, G. P., Herlyn, M., & Tuveson, D. A. (2003) · PubMed · Cited by 455
Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043802 · Cited by 453
B-RAF is a therapeutic target in melanoma
Karasarides, M., Chiloeches, A., Hayward, R., Niculescu-Duvaz, D., Scanlon, I., Friedlos, F., Ogilvie, L., Hedley, D., Martin, J., Marshall, C. J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207785 · Cited by 426
Self-citationCooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394
Self-citationV599EB-RAF is an Oncogene in Melanocytes
Wellbrock, C., Ogilvie, L., Hedley, D., Karasarides, M., Martin, J., Niculescu-Duvaz, D., Springer, C. J., & Marais, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3433 · Cited by 344
Self-citationAcquired Precursors of Cutaneous Malignant Melanoma: The Familial Dysplastic Nevus Syndrome
Greene, M. H., Clark, W. H., Tucker, M. A., Elder, D. E., Kraemer, K. H., Guerry, D., Witmer, W. K., Thompson, J., Matozzo, I., & Fraser, M. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501103120205 · Cited by 336
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 310
UKCCCR guidelines for the welfare of animals in experimental neoplasia
(1988) · Laboratory Animals · doi:10.1258/002367788780746467 · Cited by 308
Ackermann, J., Frutschi, M., Kaloulis, K., McKee, T., Trumpp, A., & Beermann, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2970 · Cited by 306
Zembowicz, A., Carney, J. A., & Mihm, M. C. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200401000-00002 · Cited by 270
Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma Models
Hoeflich, K. P., Gray, D. C., Eby, M. T., Tien, J. Y., Wong, L., Bower, J., Gogineni, A., Zha, J., Cole, M. J., Stern, H. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2720 · Cited by 232
Mutations of the BRAF Gene in Benign and Malignant Melanocytic Lesions
Yazdi, A. S., Palmedo, G., Flaig, M. J., Puchta, U., Reckwerth, A., Rütten, A., Mentzel, T., Hügel, H., Hantschke, M., Schmid-Wendtner, M.-H., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12559.x · Cited by 221
Human melanocyte senescence and melanoma susceptibility genes
Bennett, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206446 · Cited by 212
Pigmented epithelioid melanocytoma
Ward, J. R., Brady, S. P., Tada, H., & Levin, N. A. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02883.x · Cited by 205
CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma
Aitken, J., Welch, J., Duffy, D., Milligan, A., Green, A., Martin, N., & Hayward, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.446 · Cited by 200
Mercer, K., Giblett, S., Green, S., Lloyd, D., DaRocha Dias, S., Plumb, M., Marais, R., & Pritchard, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2211 · Cited by 179
Self-citationHolland, E. A., Schmid, H., Kefford, R. F., & Mann, G. J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199908)25:4<339::aid-gcc5>3.0.co;2-h · Cited by 122
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model
Kannan, K., Sharpless, N. E., Xu, J., O’Hagan, R. C., Bosenberg, M., & Chin, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336397100 · Cited by 120
Induction of melanoma in TPras transgenic mice
Powell, M. B., Gause, P. R., Hyman, P., Gregus, J., Lluria-Prevatt, M., Nagle, R. B., & Bowden, G. T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1747 · Cited by 100
Cholera Toxin Mimics Melanocyte Stimulating Hormone in Inducing Differentiation in Melanoma Cells
O’Keefe, E. J., & Cuatrecasas, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.6.2500 · Cited by 94
Spatiotemporal gene control by the Cre‐ERT2 system in melanocytes
Yajima, I., Belloir, E., Bourgeois, Y., Kumasaka, M. Y., Delmas, V., & Larue, L. (2006) · genesis · doi:10.1002/gene.20182 · Cited by 90
Self-citationPowell, M. B., Hyman, P., Bell, O. D., Balmain, A., Brown, K., Alberts, D., & Bowden, G. T. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120205 · Cited by 84
Control of Melanocyte Proliferation and Differentiation in the Mouse Epidermis
Hirobe, T. (1992) · Pigment Cell Research · doi:10.1111/j.1600-0749.1992.tb00776.x · Cited by 79
CDKN2A Germline Mutations in Individuals with Cutaneous Malignant Melanoma
Orlow, I., Begg, C. B., Cotignola, J., Roy, P., Hummer, A., Clas, B. A., Mujumdar, U., Canchola, R., Armstrong, B. K., Kricker, A., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700689 · Cited by 74
Ruiz, A., Puig, S., Malvehy, J., Lázaro, C., Lynch, M., Giménez‐Arnau, A. M., Puig, L., Sánchez-Conejo, J., Estivill, X., & CASTEL, T. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.6.490 · Cited by 66
An Inducible Mouse Model of Melanoma Expressing a Defined Tumor Antigen
Huijbers, I. J., Krimpenfort, P., Chomez, P., van der Valk, M. A., Song, J., Inderberg, E. M., Schmitt‐Verhulst, A., Berns, A. J. M., & den Eynde, B. J. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3216 · Cited by 59
Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma
Sanki, A., Li, W., Colman, M. H., Karim, R. Z., Thompson, J. F., & Scolyer, R. A. (2007) · Pathology · doi:10.1080/00313020701684409 · Cited by 59
New developments in melanoma genetics
Hayward, N. K. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0022-z · Cited by 57
Pavel, S., Smit, N. P. M., van der Meulen, H., Kolb, R. M., de Groot, A. J. L., van der Velden, P. A., Gruis, N. A., & Bergman, W. (2003) · Melanoma Research · doi:10.1097/00008390-200304000-00010 · Cited by 18
Sirigu, P., Piras, F., Minerba, L., Murtas, D., Maxia, C., Colombari, R., Corbu, A., Perra, M. T., & Ugalde, J. (2006) · PubMed · doi:10.4081/992 · Cited by 14
Tuthill, R. J., & Reed, R. J. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.09.014 · Cited by 12
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Heidorn, S. J., Milagre, C., Whittaker, S., Nourry, A., Niculescu-Duvas, I., Dhomen, N., Hussain, J., Reis-Filho, J. S., Springer, C. J., Pritchard, C., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.040 · Cited by 1,465
Self-citationSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124
Metadata
- Authors
- Dhomen, N., Reis-Filho, J. S., da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C., & Marais, R.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 15
- Issue
- 4
- Pages
- 294-303
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2019544036
- Cited by
- 594
- References
- 41
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.